Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS



Status:Active, not recruiting
Conditions:Arthritis, Arthritis, Neurology, Neurology, Orthopedic
Therapuetic Areas:Neurology, Rheumatology, Orthopedics / Podiatry
Healthy:No
Age Range:18 - Any
Updated:4/5/2019
Start Date:September 2015
End Date:April 2020

Use our guide to learn which trials are right for you!

Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis (axSpA) Without X-Ray Evidence of Ankylosing Spondylitis (AS) and Objective Signs of Inflammation

Patients with active Axial Spondyloarthritis without x-ray evidence of Ankylosing Spondylitis
and with signs of inflammation will be randomly assigned to receive certolizumab pegol (CZP)
200 mg every two weeks or placebo. The primary objective is to demonstrate the efficacy of
CZP in these patients.


Inclusion Criteria:

- At least 18 years old at the start of Screening Visit

- A documented diagnosis of adult-onset axial SpondyloArthritis (axSpA) and meet the
Assessment of SpondyloArthritis International Society (ASAS) criteria for axSpA

- Subjects must have had back pain for at least 12 months before Screening

- No sacroiliitis defined by Modified New York (mNY) criteria on sacroiliac (SI) x-rays

- Active disease at Screening as defined by

- Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score >= 4

- Spinal pain >= 4 on a 0 to 10 Numerical Rating Scale (NRS)

- Inadequate response to, have a contraindication to, or have been intolerant to at
least 2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Exclusion Criteria:

- Diagnosis of AS or any other Inflammatory Arthritis

- Prior treatment with any experimental biological agents for treatment of Axial
SpondyloArthritis (SpA)

- Exposure to more than 1 tumor necrosis factor (TNF)-antagonist or primary failure to
TNF antagonist therapy

- History of or current chronic or recurrent infections

- Subjects with known Tuberculosis (TB) infection, at high risk of acquiring TB
infection, or latent Tuberculosis (LTB)

- Recent live vaccination

- Concurrent malignancy or a history of malignancy

- Class III or IV congestive heart failure - New York Heart Association (NYHA)

- Demyelinating disease of the central nervous system

- Female subjects who are breastfeeding, pregnant or plan to become pregnant during the
study or within 3 months following the last dose of the investigational product

- Subjects with any other condition which, in the investigator's judgment, would make
the subject unsuitable for inclusion in the study
We found this trial at
38
sites
Birmingham, Alabama
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Atlanta, Georgia
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Beverly Hills, California
?
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Birmingham, Alabama
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Boston, Massachusetts
?
mi
from
Boston, MA
Click here to add this to my saved trials
Brooklyn, New York
?
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Camperdown,
?
mi
from
Camperdown,
Click here to add this to my saved trials
Charlotte, North Carolina
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
Cumberland, Maryland
?
mi
from
Cumberland, MD
Click here to add this to my saved trials
Cumberland, Maryland
?
mi
from
Cumberland, MD
Click here to add this to my saved trials
Daytona Beach, Florida
?
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
DeBary, Florida
?
mi
from
DeBary, FL
Click here to add this to my saved trials
Duncansville, Pennsylvania 16635
?
mi
from
Duncansville, PA
Click here to add this to my saved trials
Eagan, Minnesota
?
mi
from
Eagan, MN
Click here to add this to my saved trials
Fort Lauderdale, Florida
?
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Idaho Falls, Idaho
?
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Manitowoc, Wisconsin
?
mi
from
Manitowoc, WI
Click here to add this to my saved trials
New Haven, Connecticut
?
mi
from
New Haven, CT
Click here to add this to my saved trials
New Port Richey, Florida
?
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Oklahoma City, Oklahoma
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Onalaska, Wisconsin 54650
?
mi
from
Onalaska, WI
Click here to add this to my saved trials
Orangeburg, South Carolina
?
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Palm Desert, California
?
mi
from
Palm Desert, CA
Click here to add this to my saved trials
Philadelphia, Pennsylvania
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Plantation, Florida
?
mi
from
Plantation, FL
Click here to add this to my saved trials
Portland, Oregon
?
mi
from
Portland, OR
Click here to add this to my saved trials
Rochester, Minnesota
?
mi
from
Rochester, MN
Click here to add this to my saved trials
Saint Louis, Missouri
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Salt Lake City, Utah
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
San Francisco, California
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Scottsdale, Arizona
?
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Seattle, Washington
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Tampa, Florida
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Tucson, Arizona
?
mi
from
Tucson, AZ
Click here to add this to my saved trials
Vero Beach, Florida
?
mi
from
Vero Beach, FL
Click here to add this to my saved trials
Wheaton, Maryland
?
mi
from
Wheaton, MD
Click here to add this to my saved trials
Worcester, Massachusetts
?
mi
from
Worcester, MA
Click here to add this to my saved trials
Wyomissing, Pennsylvania
?
mi
from
Wyomissing, PA
Click here to add this to my saved trials